Get 30% off on all global market reports with code ONLINE30 – stay updated on tariff changes, macroeconomic trends, and more!
How Has the Minimal Residual Disease Testing Market Size Shifted in Recent Years?
The market size for minimal residual disease testing has experienced a swift expansion over the past few years. Forecasts predict a surge from $1.59 billion in 2024 to $1.8 billion in 2025, with a compound annual growth rate (CAGR) of 12.9%. This significant growth during the historical period can be attributed to factors such as developments in cancer research, the need for treatment monitoring, clinical proof, regulatory endorsement, and improvements in patient outcomes.
In the upcoming years, the market size of minimal residual disease testing is expected to experience substantial growth, reaching $2.91 billion in 2029 with a compound annual growth rate (CAGR) of 12.8%. Factors contributing to the growth in this forecast period include a surge in cancer cases, advancements in therapeutic practices, trends in precision medicine, a shift towards early diagnosis, and integration of healthcare systems. Key trends for this forecast period encompass the incorporation of liquid biopsy techniques, emphasis on early relapse detection, the expansion of MRD testing in clinical trials, rising applicability in pediatric oncology, and partnerships for research and development.
Claim Your Free Sample Report:
http://www.thebusinessresearchcompany.com/sample….p;type=smp
Which Market Conditions Are Fueling the Growth of the Minimal Residual Disease Testing Industry?
The minimal residual disease testing market is predicted to grow due to the increasing incidence of cancer. Cancer is defined as a state in which a small number of the body’s cells develop uncontrollably and metastasize to other parts of the body. Minimal residual disease testing, a highly sensitive way to identify cancer cells in the body, is primarily used to determine the stages of cancer. This testing aids in nipping the disease in the bud for cancer patients, thereby fueling the growth of the minimal residual disease testing market.
For example, the American Cancer Society Inc., a nonprofit organization based in the US, reported in 2022 that about 1.9 million new cases of cancer are expected to be diagnosed, resulting in an estimated 609,360 cancer-related deaths in the United States in 2022. Hence, the rising incidence of cancer is catalyzing the expansion of the minimal residual disease testing market.
Performance of Leading Segments in the Minimal Residual Disease Testing Global Market
The minimal residual disease testing market covered in this report is segmented –
1) By Test Type: DNA – Based Test, RNA- Based Test, Immunological Test
2) By Technology: Flow Cytometry, Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Other Technologies
3) By Application: Hematological Malignancies, Leukemia, Lymphoma, Solid Tumors, Other Application
4) By End User: Hospitals And Specialty Clinics, Diagnostic Laboratories, Academic And Research Institutes, Other End Users
Subsegments:
1) By DNA-Based Test: Polymerase Chain Reaction (PCR) Tests, Next-Generation Sequencing (NGS), Digital PCR
2) By RNA-Based Test: Reverse Transcription PCR (RT-PCR), RNA Sequencing, Quantitative PCR (qPCR)
3) By Immunological Test: Flow Cytometry, Enzyme-Linked Immunosorbent Assay (ELISA), Immunohistochemistry
Access the Full Report Today:
http://www.thebusinessresearchcompany.com/report/…ket-report
What Trends Will Shape the Evolution of the Minimal Residual Disease Testing Market?
A rising trend in the minimal residual disease testing market is product innovation. To maintain their market prominence, major firms engaged in this field are introducing innovative products. For instance, in 2022, Twist Bioscience, an American synthetic biology and genomics firm, unveiled the Twist MRD Panel, propelling progress in research and development related to the detection of minimal residual disease (MRD) during cancer screenings. This is a tailor-made panel of genes for detecting residual cancer cells at extraordinarily low levels in patient blood samples. The Twist MRD Panel has been designed for immense flexibility and adaptability and can be seamlessly integrated into a standard next-generation sequencing (NGS) process, enabling MRD detection within a mere five days.
What Are the Regional Hotspots for Minimal Residual Disease Testing Market Growth?
North America was the largest region in the minimal residual disease testing market in 2024. The regions covered in the minimal residual disease testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Get a Customized Version of the Report:
http://www.thebusinessresearchcompany.com/customi…p;type=smp
Which Companies Hold the Largest Market Share in the Minimal Residual Disease Testing Industry?
Major companies operating in the minimal residual disease testing market include Natera Inc., Guardant Health Inc., Laboratory Corporation of America Holdings, QIAGEN NV, F. Hoffmann-La Roche Ltd., Bio-Techne Corporation, Bio-Rad Laboratories Inc., Sysmex Corporation, Exact Sciences Corporation, GRAIL LLC, Veracyte Inc., Cergentis B.V, Mdxhealth SA, NeoGenomics Laboratories Inc., Adaptive Biotechnologies, OPKO Health Inc., Thermo Fisher Scientific Inc., Siemens Healthineers AG, PerkinElmer Inc., Agilent Technologies Inc., ArcherDx Inc., Asuragen Inc., Becton, Dickinson and Company, Cepheid Inc., Fluidigm Corporation, Illumina Inc., Invitae Corporation, Janssen Diagnostics LLC, Luminex Corporation, Menarini Silicon Biosystems S.p.A.
Access the Complete Report:
http://www.thebusinessresearchcompany.com/purchas…px?id=9970
How Our Market Research Reports Help Maximize ROI Across Industries:
* Identify High-Growth Opportunities: Pinpoint emerging trends, untapped segments, and regional hotspots that align with your strategic goals.
* Reduce Investment Risk: Make data-driven decisions with confidence by understanding market dynamics, key drivers, and competitive threats.
* Optimize Strategic Planning: Align your product development, marketing, and expansion plans with industry forecasts and customer behaviour insights.
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
News From
The Business Research Company …
Category: Industry Reports & Market Analysis Profile: The Business Research Company is a leading market research and consulting services provider. It offers over 9,500 market reports across 27 industries in 60+ geographies, providing detailed insights and forecasts. Its customised research solutions support companies in making critical decisions, while its continuous research service enhances organizational capabilities. The flagship Global Market Model database provides comprehensive market intelligence with 1,500,000 datasets covering 8,000+ mark …
This email address is being protected from spambots. You need JavaScript enabled to view it.
